£375 million Future Fund: Breakthrough opens for applications to help high-growth, R&D intensive companies bring game-changing technologies to market.

The fund is designed to provide equity funding to innovative, R&D-intensive UK companies operating in breakthrough technology sectors (such as quantum, clean tech, and life sciences). These are sectors which typically have a longer lead time to product commercialisation.

The fund is focused where there is the greatest need for intervention to increase the investment round size.

Future Fund: Breakthrough is an investor led programme, which means funding applications can only be made by a qualifying lead investor and cannot be made by companies.

Find out more on the British Patient Capital website.